Clintelligence
- Company typePrivate
- Founded-
- Headquarters—
- Headcount—
- GTM typeB2B and B2C
- OfferingSoftware
Clintelligence firmographics
Firmographics- Name
- Clintelligence
- Legal name
- Jeeva Clinical Trials Inc.
- Website
- https://trialclintelligence.com
- Company type
- Private
- Operating status
- Operating
- Ownership category
- akta.pro rank
Clintelligence industry classification
Industry- Product category
- Clinical Trial Intelligence Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
- akta.pro secondary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Clintelligence business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
Revenue model
- Protocol Analysis Platform: AI-powered analysis platform for clinical trial protocol optimization. The platform offers free trial access with likely conversion to paid subscription for continued access to analysis features and API usage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Trial |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Clintelligence product offering
Product offeringCore offering
Clintelligence sells an AI-powered clinical trial protocol intelligence SaaS platform that analyzes user-uploaded protocols against a database of 500K-566K+ historical trials to predict risks, forecast enrollment, optimize eligibility and endpoints, and recommend site strategies. It also provides a Patient Trial Matching service that screens patients against 95,000+ actively recruiting trials using eligibility criteria and location, and an Analysis Dashboard consolidating competitive landscape, protocol design, and operational intelligence. The product is delivered via self-serve web application with freemium entry and is part of Jeeva Clinical Trials Inc.
Product overview
Clintelligence is an AI-powered protocol intelligence platform offered by Jeeva Clinical Trials Inc. The platform consists of three core integrated components: (1) Protocol Analysis for uploading and analyzing protocol documents, (2) Patient Trial Matching for connecting patients with relevant studies, and (3) an Analysis Dashboard providing comprehensive intelligence across competitive landscape, protocol design, and operations modules. The system analyzes protocols against a database of 566K+ historical clinical trials to provide risk assessment, amendment prediction, enrollment forecasting, site intelligence, and optimization recommendations.
Differentiator
Problem solved
Functional benefit
Brands
- Protocol Intelligence: AI-powered protocol analysis platform for clinical trial design optimization
- Jeeva Trials
Products and services
- Protocol Analysis AI-powered protocol analysis module where clinical trial sponsors upload protocol text or PDF documents. The system extracts key information automatically, compares the protocol against 500K+ historical clinical trials, identifies risks, optimizes endpoints, predicts success rates, forecasts enrollment, and recommends site strategies. Targeted at pharmaceutical, biotech, and CRO sponsors designing new studies.
- Patient Trial Matching AI-powered patient-to-trial matching service that helps patients find clinical trials matching their specific conditions and eligibility criteria. Features intelligent eligibility screening, location-based matching, match score ranking, and direct site contact capabilities. Searches 95,000+ actively recruiting trials. Targeted at individual patients and caregivers seeking clinical trial opportunities.
- Analysis Dashboard Comprehensive analytics dashboard providing protocol intelligence across four modules: Overview (executive summary with key metrics), Competitive Landscape (similar trials analysis and sponsor track record), Protocol Design (optimization, eligibility, endpoints, amendment risk), and Operations (site intelligence, enrollment forecast, risk analysis). Targeted at clinical trial sponsors and researchers needing consolidated intelligence on protocol decisions.
Quantifiable outcome
- 85% risk prediction accuracy for clinical trial protocols
- +3 more outcomes
Companies that use Clintelligence
Customer profileSegments3 records
Ideal customer profiles2 records
Clintelligence technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Clintelligence partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Jeeva Clinical Trials Inc.coreClintelligence is branded as 'A Jeeva Clinical Product' and falls under Jeeva Clinical Trials Inc. (© 2026). The platform is integrated with the Jeeva Trials ecosystem, linking to jeevatrials.com. This represents a product within the Jeeva Clinical portfolio rather than an independent partnership.
Scale indicators8 records
Recent moves5 records
Expansion highlights5 records
Clintelligence competitors and assessment
Company assessmentEmerging players
- Curebase: Decentralized clinical trial software and virtual site platform. Adjacent competitor focused on modernizing trial execution, intersecting with Clintelligence's site intelligence and patient matching modules.
- Castor: Decentralized clinical trial platform with ePRO/eCRF and remote data capture. Adjacent competitor targeting modern, tech-forward sponsors similar to Clintelligence's customer profile.
- TrialGPT (NIH/ OpenAI): OpenAI-developed clinical trial matching research initiative using LLMs to match patients to trials. Represents a potential open-source/free competitive threat to Clintelligence's matching module.
Direct peers
- Trial Library: Clinical trial intelligence and protocol feasibility analytics platform. Closely comparable to Clintelligence's protocol benchmarking and site intelligence modules.
- Deep 6 AI: AI-powered patient-trial matching and protocol analysis platform. Directly comparable to Clintelligence's patient-trial matching and protocol design optimization modules.
- Mendel: AI platform that structures clinical trial and medical record data for trial design, patient matching, and protocol optimization—directly overlapping Clintelligence's core feature set.
- Protocol First: AI-enabled protocol design and feasibility platform for sponsors and CROs. Competes head-to-head with Clintelligence on protocol risk prediction and optimization.
Broad incumbents
- Medidata (Dassault Systèmes): Industry-leading EDC, RTSM, and clinical trial platform. While focused on data capture, its growing analytics and protocol intelligence suite competes broadly with Clintelligence's value proposition for sponsors.
- Veeva Systems: Cloud software for life sciences, including CTMS and clinical operations suites. Provides overlapping functionality for clinical trial sponsors and represents a broad incumbent alternative.
- IQVIA: Largest CRO and life sciences technology provider, with EDC, RTSM, and trial design analytics. Represents a broad incumbent competitor with deep sponsor relationships that Clintelligence must displace.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Clintelligence financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clintelligence leadership team
Management profileNumber of profiles
Clintelligence funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clintelligence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clintelligence
What does Clintelligence do?
Clintelligence sells an AI-powered clinical trial protocol intelligence SaaS platform that analyzes user-uploaded protocols against a database of 500K-566K+ historical trials to predict risks, forecast enrollment, optimize eligibility and endpoints, and recommend site strategies. It also provides a Patient Trial Matching service that screens patients against 95,000+ actively recruiting trials using eligibility criteria and location, and an Analysis Dashboard consolidating competitive landscape, protocol design, and operational intelligence. The product is delivered via self-serve web application with freemium entry and is part of Jeeva Clinical Trials Inc.
Is Clintelligence a public or private company?
Clintelligence is a private company. It is classified as corporate owned and is currently operating.
When was Clintelligence founded?
Clintelligence was founded in -1.
How does Clintelligence make money?
One revenue line is on record: protocol Analysis Platform.
Who are Clintelligence's main competitors?
Emerging players on record are Curebase, Castor and TrialGPT (NIH/ OpenAI). Direct peers are Trial Library, Deep 6 AI, Mendel and Protocol First. Broad incumbents are Medidata (Dassault Systèmes), Veeva Systems and IQVIA.
Does Clintelligence have an API?
No public API is recorded for Clintelligence.
What industry is Clintelligence in?
Clintelligence's product category is Clinical Trial Intelligence Software. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 5132 and its SIC code is 7372.